[go: up one dir, main page]

SE7310986L - Forfarande for framstellning av emnen lempliga sasom lekemedel. - Google Patents

Forfarande for framstellning av emnen lempliga sasom lekemedel.

Info

Publication number
SE7310986L
SE7310986L SE7310986A SE7310986A SE7310986L SE 7310986 L SE7310986 L SE 7310986L SE 7310986 A SE7310986 A SE 7310986A SE 7310986 A SE7310986 A SE 7310986A SE 7310986 L SE7310986 L SE 7310986L
Authority
SE
Sweden
Prior art keywords
lempliga
sasom
toys
preparing
procedure
Prior art date
Application number
SE7310986A
Other languages
English (en)
Other versions
SE415354B (sv
Inventor
H-J Hinze
A Soder
K Popendiker
W Mohler
M Jayme
J Komarek
M Reiser
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE7310986L publication Critical patent/SE7310986L/sv
Publication of SE415354B publication Critical patent/SE415354B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7310986A 1973-07-11 1973-08-10 Forfarande for framstellning av xantinderivat SE415354B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2335170A DE2335170C2 (de) 1973-07-11 1973-07-11 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
SE7310986L true SE7310986L (sv) 1975-01-13
SE415354B SE415354B (sv) 1980-09-29

Family

ID=5886518

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7310986A SE415354B (sv) 1973-07-11 1973-08-10 Forfarande for framstellning av xantinderivat

Country Status (17)

Country Link
US (1) US4108995A (sv)
AR (4) AR199915A1 (sv)
AT (1) AT333300B (sv)
BE (1) BE816869R (sv)
CA (1) CA1062709A (sv)
CH (4) CH587850A5 (sv)
DE (1) DE2335170C2 (sv)
DK (1) DK147004C (sv)
ES (3) ES417828A1 (sv)
FI (1) FI61703C (sv)
FR (1) FR2236501B2 (sv)
GB (1) GB1480836A (sv)
IE (1) IE41822B1 (sv)
NL (1) NL168703C (sv)
NO (2) NO140596C (sv)
SE (1) SE415354B (sv)
ZA (1) ZA744373B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207321A (en) * 1977-04-02 1980-06-10 Hoechst Aktiengesellschaft Pharmaceutical compositions containing xanthines
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US5338741A (en) * 1986-10-27 1994-08-16 Nestec S.A. 1-hydroxyalkylxanthines and medicaments containing them
DE3725554A1 (de) * 1987-08-01 1989-02-09 Hoechst Ag Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung
DE3942871A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag R-(-)-1-(5-hydroxyhexyl)-3-methyl-7-propylxanthin, verfahren zu dessen herstellung und diese verbindung enthaltende arzneimittel
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
DE926788C (de) * 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
AR199915A1 (es) 1974-10-08
IE41822B1 (en) 1980-04-09
CH587853A5 (sv) 1977-05-13
NO143064C (no) 1980-12-10
NO140596B (no) 1979-06-25
AT333300B (de) 1976-11-10
CH587851A5 (sv) 1977-05-13
BE816869R (fr) 1974-12-27
FR2236501A2 (sv) 1975-02-07
SE415354B (sv) 1980-09-29
AR200626A1 (es) 1974-11-22
ATA684573A (de) 1976-03-15
NL7311123A (nl) 1975-01-14
AR202662A1 (es) 1975-06-30
DK147004C (da) 1984-08-20
NL168703B (nl) 1981-12-16
US4108995A (en) 1978-08-22
ES437150A1 (es) 1977-01-16
DK438373A (sv) 1975-03-03
ES417828A1 (es) 1976-03-16
CH587852A5 (sv) 1977-05-13
FI61703C (fi) 1982-09-10
FR2236501B2 (sv) 1979-08-10
AR202663A1 (es) 1975-06-30
NO790627L (no) 1975-01-14
FI206574A (sv) 1975-01-12
CH587850A5 (sv) 1977-05-13
NO143064B (no) 1980-09-01
AU7101974A (en) 1976-01-15
ES437151A1 (es) 1977-01-16
ZA744373B (en) 1975-07-30
DE2335170C2 (de) 1989-07-20
NO140596C (no) 1979-10-03
CA1062709A (en) 1979-09-18
DE2335170A1 (de) 1975-01-30
NO742464L (sv) 1975-02-10
DK147004B (da) 1984-03-12
FI61703B (fi) 1982-05-31
NL168703C (nl) 1982-05-17
GB1480836A (en) 1977-07-27
IE41822L (en) 1975-01-11

Similar Documents

Publication Publication Date Title
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
DE3170245D1 (en) Indane derivatives, methods of their preparation and compositions containing them
SE7310986L (sv) Forfarande for framstellning av emnen lempliga sasom lekemedel.
ES439927A1 (es) Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
ES427079A1 (es) Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7.
SE7906011L (sv) Nya imidazokinoxaliner och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
IE44339L (en) Piperazine derivatives.
GB1250208A (sv)
EP0066909A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and processes for their production
ES478984A1 (es) Procedimiento de preparacion de productos del grupo de la e-burnamenina.
GB1500962A (en) Furo(2,3-d)pyrimidine derivatives
ES486049A1 (es) Procedimiento para la obtencion de derivados aminopropanoli-cos de la 6-hidroxi-2,3,4,5-tetrahidro-1h-1-benzazepin-2-ona
GB1361863A (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB1312205A (en) Method and composition for lowering blood pressure
FR2453865A1 (fr) Derives de cephalosporine, leurs procedes de preparation, et medicaments antibacteriens contenant ces derives
GB1362400A (en) 1-amino-isoquinoline derivatives
DK162286C (da) Penemderivat, farmaceutisk praeparat indeholdende dette, anvendelse af derivatet samt fremgangsmaader til fremstilling deraf
FR2453850A1 (fr) Nouveaux derives de 16-methoxy-16-methyl-prostaglandine e1 utiles notamment comme agents gastroprotecteurs et leur procede de preparation
GB1342643A (en) Thioacetanilide derivatives
GB1417323A (en) Physiologically active xanthine compounds and compositions containing them
GB1268747A (en) Novel 2-naphthyl-2-hydroxy-acetamidine derivatives, their preparation and use
IE45735L (en) Glycinamides
GB1295240A (sv)
GB1250209A (sv)